Why the study?
Does levosimendan improve haemodynamics and myocardial substrate utilization in low-risk patients early after coronary artery bypass grafting?
Population
23 low-risk patients early after coronary artery bypass grafting
Comparison
Levosimendan 8 or 24 micrograms.kg-1 vs Placebo
Design
RCT, randomized, double-blind
Follow-up
early after coronary artery bypass grafting
Authors
Loading...
Supports levosimendan for post-CABG hemodynamic support without raising myocardial oxygen consumption; extends prior data to the early postoperative period.
Does levosimendan improve haemodynamics and myocardial substrate utilization in low-risk patients early after coronary artery bypass grafting?
Levosimendan improves cardiac output and decreases vascular resistance without increasing myocardial oxygen consumption in patients after CABG.
Jyrki Lilleberg (1998) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: